VSX1
Basic information
Region (hg38): 20:25070885-25082141
Previous symbols: [ "PPCD" ]
Links
Phenotypes
GenCC
Source:
- keratoconus 1 (Limited), mode of inheritance: AD
- posterior polymorphous corneal dystrophy (Supportive), mode of inheritance: AD
- craniofacial anomalies and anterior segment dysgenesis syndrome (Limited), mode of inheritance: AD
- keratoconus 1 (Limited), mode of inheritance: AD
- posterior polymorphous corneal dystrophy 1 (Limited), mode of inheritance: Unknown
- keratoconus 1 (Limited), mode of inheritance: Unknown
- craniofacial anomalies and anterior segment dysgenesis syndrome (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Craniofacial anomalies and anterior segment dysgenesis syndrome; Keratoconus 1; Corneal dystrophy, posterior polymorphous | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Ophthalmologic | 11978762; 15051220; 15623752; 16735990; 18216574; 18626569; 19763142; 19956409; 20664914; 21365019; 21976959; 26045363 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VSX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 20 | ||||
missense | 39 | 50 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 13 | 24 | ||||
Total | 0 | 0 | 57 | 21 | 20 |
Variants in VSX1
This is a list of pathogenic ClinVar variants found in the VSX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-25071957-G-A | Uncertain significance (-) | |||
20-25075441-A-G | Polymorphous corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
20-25075512-G-A | Polymorphous corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
20-25075516-C-T | Polymorphous corneal dystrophy | Benign (Jan 13, 2018) | ||
20-25075517-G-T | Polymorphous corneal dystrophy | Benign (Jan 13, 2018) | ||
20-25075651-C-T | Polymorphous corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
20-25075755-A-G | Polymorphous corneal dystrophy | Uncertain significance (Jun 14, 2016) | ||
20-25075765-T-C | Polymorphous corneal dystrophy | Benign (Jan 13, 2018) | ||
20-25075807-TC-T | Polymorphous corneal dystrophy | Benign (Jun 14, 2016) | ||
20-25075845-A-G | Polymorphous corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
20-25075865-A-C | Polymorphous corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
20-25076038-C-T | Polymorphous corneal dystrophy | Uncertain significance (Jun 14, 2016) | ||
20-25076061-C-A | Polymorphous corneal dystrophy | Benign (Jan 12, 2018) | ||
20-25076062-C-T | Polymorphous corneal dystrophy | Benign (Jan 12, 2018) | ||
20-25076092-C-T | Polymorphous corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
20-25076102-C-T | Polymorphous corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
20-25076149-T-C | Polymorphous corneal dystrophy | Uncertain significance (Jan 12, 2018) | ||
20-25076157-G-A | Polymorphous corneal dystrophy | Benign (Jan 13, 2018) | ||
20-25076172-A-G | Polymorphous corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
20-25076173-G-C | Polymorphous corneal dystrophy | Uncertain significance (Jan 13, 2018) | ||
20-25076197-C-A | Polymorphous corneal dystrophy | Uncertain significance (Apr 27, 2017) | ||
20-25076258-G-T | Polymorphous corneal dystrophy | Likely benign (Apr 27, 2017) | ||
20-25076292-C-T | Inborn genetic diseases | Uncertain significance (Feb 12, 2024) | ||
20-25076326-C-A | Inborn genetic diseases | Uncertain significance (Oct 03, 2022) | ||
20-25076362-G-A | Uncertain significance (Mar 11, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VSX1 | protein_coding | protein_coding | ENST00000376709 | 5 | 11476 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0359 | 0.932 | 125739 | 0 | 7 | 125746 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.482 | 181 | 200 | 0.904 | 0.00000988 | 2281 |
Missense in Polyphen | 49 | 63.666 | 0.76964 | 723 | ||
Synonymous | -0.917 | 97 | 86.2 | 1.13 | 0.00000426 | 788 |
Loss of Function | 1.85 | 4 | 10.5 | 0.382 | 5.35e-7 | 108 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to the 37-bp core of the locus control region (LCR) of the red/green visual pigment gene cluster. May regulate the activity of the LCR and the cone opsin genes at earlier stages of development.;
- Disease
- DISEASE: Craniofacial anomalies and anterior segment dysgenesis syndrome (CAASDS) [MIM:614195]: A disorder with extremely variable expressivity. Clinical features include wide interpupillary distance, abnormal corneal endothelium, unusual pinnae, partially to completely empty sella turcica, posterior fossa cyst, anterior encephalocele, and/or hydrocephalus. {ECO:0000269|PubMed:15051220}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.137
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- N
- hipred_score
- 0.209
- ghis
- 0.428
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.349
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vsx1
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- vsx1
- Affected structure
- ventricular system
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;visual perception;neuron maturation;neuron development;response to stimulus;retinal bipolar neuron differentiation
- Cellular component
- cellular_component;nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;chromatin binding;DNA-binding transcription factor activity;sequence-specific DNA binding;transcription regulatory region DNA binding